Goodwin Procter advised the initial purchasers on the deal. Sarepta Therapeutics, Inc. announced its Rule 144A offering of 1.25% Convertible Senior Notes due 2027. The $1.15 billion...
Sarepta Therapeutics’ $1.15 Billion Notes Offering
Wayfair’s $690 Million Convertible Senior Notes Offering
Goodwin Procter represented Wayfair, while Davis Polk advised the representatives of the initial purchasers in the offering. Wayfair Inc. completed its offering of $690 million aggregate principal...
Thoma Bravo’s AUD $1.055 Billion Acquisition of Nearmap
Goodwin Procter advised Thoma Bravo on the deal. Thoma Bravo, a leading software investment firm, announced its definitive agreement to acquire 100% of the shares in...
Universal Navigation’s Acquisition of Genie
Goodwin advised Universal Navigation, Inc. on the deal. Universal Navigation, Inc. (Uniswap) announced its acquisition of NFT marketplace aggregator Genie. Uniswap plans to integrate NFTs into its...
Shopify’s Acquisition of Deliverr
Goodwin Procter advised Deliverr, Inc. on the deal, while Paul, Weiss advised Shopify. Deliverr, Inc. announced its agreement to be acquired by Shopify Inc. (NYSE, TSX: SHOP)....
Vista and Evergreen’s $16.5 Billion Acquisition of Citrix
Kirkland & Ellis and Kinstellar advised Vista, and Gibson, Dunn & Crutcher and Debevoise & Plimpton advised Evergreen. Goodwin Procter represented Citrix in the transaction. Wilson...
Global Blood Therapeutics’ $345 Million Notes Offering
Goodwin Procter advised Global Blood Therapeutics on the deal. Global Blood Therapeutics, Inc. (Nasdaq: GBT) announced its offering of 1.875% Convertible Senior Notes due 2028. The...
Sinch AB’s $1.9 Billion Acquisition of Pathwire
Goodwin Procter advised Pathwire on the deal, while K&L Gates and Gernandt & Danielsson advised Sinch AB. Pathwire, along with its private equity owner Thoma Bravo...
AbCellera’s Acquisition of TetraGenetics
Goodwin Procter advised AbCellera on the deal. AbCellera (Nasdaq: ABCL) announced its acquisition of TetraGenetics. AbCellera is a technology company with a centralized operating system for next-generation...
Synaptics Incorporated’s Acquisition of DSP Group
Goodwin Procter advised Synaptics Incorporated on the deal while Morrison & Foerster represented DSP Group, Inc. Synaptics Incorporated (Nasdaq: SYNA) and DSP Group, Inc. (Nasdaq: DSPG)...
NightDragon’s $750 Million Fund Closing
Goodwin Procter advised NightDragon on the deal. NightDragon announced the closing of its Growth I, a new $750 million venture capital fund to invest in and advise...
Tango Therapeutics’ $353 Million Merger with BCTG Acquisition Corp.
Goodwin Procter LLP advised Tango Therapeutics on the deal while Wilson Sonsini Goodrich & Rosati represented BCTG Acquisition Corp. Tango Therapeutics announced its definitive merger agreement with...